• Shortlysts
  • Posts
  • U.S. Supreme Court Restores Access to Mifepristone for Telehealth Providers

U.S. Supreme Court Restores Access to Mifepristone for Telehealth Providers

U.S. Supreme Court restores access to mifepristone, a medication often used to induce abortions.

What Happened?

The Supreme Court restored broad access to the abortion pill mifepristone, blocking a lower-court ruling that had threatened to upend one of the main ways abortions are provided across the nation. Justice Samuel Alito signed an order that temporarily allows women seeking abortions to obtain the pill at pharmacies or through the mail, without an in-person visit to a doctor.

Medication by mail had been a standard practice for years until a federal appeals court imposed new restrictions last week. Most abortions in the United States are obtained by medication.

Why it Matters

The ruling to restore access to mifepristone represents a consequential moment in the ongoing national debate over reproductive rights, federal regulatory authority, and the role of courts in public health policy.

It is difficult to see how the Supreme Court could uphold the lower court ruling banning mail-in access to mifepristone because America’s highest court just four years ago ruled that abortion is a matter to be decided by the states, not the federal government…

4 Trillion Hours Spent on Smartphones Every Year

On average, people spend nearly 40 hours a week on their smartphones.

By enabling consumers to earn money during this time, Mode is poised to capture significant revenue and become a household name.*

The controversy surrounding mifepristone has intensified in recent years, particularly after the Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization, which overturned federal constitutional protections for abortion.

Opponents of abortion have challenged the original approval of mifepristone and subsequent regulatory changes that expanded access, including allowing the drug to be prescribed via telemedicine and mailed to patients. These challengers argue that the government did not adequately consider safety risks and that loosening restrictions has increased potential harm.

Mifepristone is a medication approved in 2000 by the U.S. Food and Drug Administration for use in medication abortions, but it has other uses, including managing high blood pressure. Over the past two decades, mifepristone has become a cornerstone of reproductive healthcare in the United States. Medication abortions now account for more than half of all abortions nationwide, largely because they are less invasive, can be administered early, and offer greater privacy and accessibility.

The Dobbs ruling held that states have the authority to regulate abortion, and that includes medication, which can be used to induce abortions. The 5th Circuit Court decision held that allowing mifepristone to be mailed in Louisiana effectively nullifies that state’s ban on abortions.

The problem is a federal ban on mifepristone through the mail would also nullify the laws of states that permit abortion. The Supreme Court will have to sort out more clearly where federal authority ends and state authority begins with respect to medically induced abortions. 

How it Affects You

With surgical abortion access increasingly limited in many states, medication abortion has become a central battleground. The legal status of drugs like mifepristone will likely remain contested, reflecting deeper divisions over reproductive rights, federalism, and the balance between science and politics.

The reason why precedent is important for the legal system is so that the entire legal structure doesn’t have to be reinvented on a frequent basis, because that would be expensive and confusing. If the Supreme Court overturns its own precedent from just four years ago, it would add confusion and uncertainty about how long any of its rulings might last.

*Disclaimer: Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering.

Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.

Smartphone usage according to Forbes.